Andrea B Apolo MDChief, Bladder Cancer Section, Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health
Dr. Andrea Apolo is a medical oncologist at the National Cancer Institute in Bethesda, Maryland, and is Chief of the Bladder Cancer Section of the Genitourinary Malignancies Branch. She is also involved in the Bladder Cancer Advocacy Network (BCAN) in several capacities including serving on the BCAN Think Tank Executive Committee and as Co-Chair of the BCAN Think Tank Program Committee, among others. She is the Co-Founder of the first DC metro area Bladder Cancer Support Group of BCAN and the Wellness Community Center and serves as the Bladder Cancer Section Editor for Current Opinion in Urology.
Dr. Apolo has been involved in numerous trials in genitourinary cancer, both as principal and lead investigator, as well as associate investigator, primarily in the areas of urothelial carcinoma and prostate cancer. She has spoken nationally on the subject of genitourinary cancers, particularly bladder cancer, and is a frequent lecturer. She is an active researcher and widely published author, with well over 80 publications including journal articles, abstracts, and book chapters. She is a peer reviewer for high-impact journals such as the Journal of Clinical Oncology, Cancer, Cancer Research, Clinical Cancer Research, and Current Opinion in Urology.
Dr. Apolo received her medical degree from Albert Einstein College of Medicine/Yeshiva University, and her residency training at New York-Presbyterian Hospital, Weill Cornell. She completed fellowship training in medical oncology at Memorial Sloan Kettering Cancer Center, where she also completed a research fellowship in the Genitourinary Oncology Service Division of Solid Tumor Oncology. In addition, she completed fellowship training in medicine at the Cornell University Medical Center in New York.